Shenzhen:300676

BGI's Real-time Fluorescent RT-PCR Kit for Detecting 2019-nCoV eligible for WHO Emergency Use Listing

SHENZHEN, China, May 11, 2020 /PRNewswire/ -- BGI Genomics announced that its Real-time fluorescent RT-PCR kit for detecting 2019-nCoV has been listed as eligible for World Health Organization (WHO) procurement under the WHO Emergency Use Listing (EUL) process.  The EUL is a risk-based procedure...

2020-05-12 02:00 3026

BGI Genomics Announces Pricing of Initial Public Offering

SHENZHEN, China, July 14, 2017 /PRNewswire/ -- BGI Genomics, an independent division of BGI Group, today announced pricing of its initial public offering of 40.1 million shares at a list price ofRMB 13.64 per share. Announces launch of IPO BG...

2017-07-14 16:37 3267